Singapore endorses Pfizer-BioNTech COVID-19 antibody for use in 12 to 15-year-olds Kumar Jeetendra | May 18, 2021 Singapore has authorised the use of the Pfizer-BioNTech COVID-19 vaccine for those aged 12 to 15 years old in a bid to extend protection to more groups as the country tackles a recent increase of infections, officials said on Tuesday.“The data showed that the Pfizer-BioNTech COVID-19 vaccine demonstrated high efficacy consistent with that observed in …
Too soon to say second wave has topped; immunization accessibility national bottleneck: CRISIL Kumar Jeetendra | May 17, 2021 Even as new COVID-19 infections have shown a declining trend, credit rating agency Crisil on Monday said it is “too early” to say that the second wave of the pandemic has peaked and flagged concerns over the vaccination drive. After opening up the vaccination for all adults, the drive has suffered because availability of vaccines …
What is the Moderna COVID immunization? Does it work, and is it safe? Kumar Jeetendra | May 16, 2021 Overnight, Boston-based pharmaceutical company Moderna announced a new supply agreement with Australia for 25 million doses of its COVID-19 vaccine. The deal includes ten million doses against the original strain of the coronavirus to be delivered this year. This vaccine has been widely used in countries such as Canada, United States and the United Kingdom …
Alembic Pharma gets USFDA gesture for bipolar depression drug Kumar Jeetendra | May 15, 2021 New Delhi, May 14 (PTI) Drug firm Alembic Pharmaceuticals on Friday said it has received final approval from the US health regulator for Lurasidone Hydrochloride tablets, used to treat bipolar depression. The approved product is therapeutically equivalent to the reference listed drug product (RLD) Latuda tablets of Sunovion Pharmaceuticals Inc. The company has received approval …
Gland Pharma gets USFDA gesture for generic Foscarnet Sodium injection Kumar Jeetendra | May 15, 2021 New Delhi, Apr 22 (PTI) Drug firm Gland Pharma on Thursday said it has received approval from the US health regulator for its generic Foscarnet Sodium injection indicated for treatment of cytomegalovirus retinitis in patients with AIDS. The company has received “approval from the United States Food and Drug Administration (USFDA) for its Foscarnet Sodium …
Cipla Enters into a Licensing Agreement with Lilly to Expand Access to COVID-19 Treatment in India Kumar Jeetendra | May 10, 2021 Mumbai, India, May 10, 2021: Cipla Limited (BSE: 500087 | NSE: CIPLA EQ, hereafter referred to as “Cipla”) today announced it has signed a royalty-free, non-exclusive voluntary licensing agreement with Eli Lilly and Company, USA for the manufacture and commercialization of the drug baricitinib for Covid-19 indication. Baricitinib was issued a restricted emergency use approval …
Sri Lanka endorses Pfizer COVID-19 vaccine for emergency use Kumar Jeetendra | May 8, 2021 Sri Lanka on Saturday approved Pfizer’s COVID-19 vaccine for emergency use in Sri Lanka, as the island nation battles a third wave of the virus, while suffering a restricted supply of vaccines from neighboring India. Dr. Sudharshani Fernandopulle, the minister overseeing the fight against the epidemic, said in a statement the government would order 5 …
EMA opens audit of China’s Sinovac Covid jab Kumar Jeetendra | May 4, 2021 The European Medicines Agency said Tuesday it has started a “rolling review” of China’s Sinovac coronavirus jab, a process that could lead to eventual approval for the European market. Made by Sinovac’s Beijing-based Life Sciences unit, the vaccine contains an inactivated coronavirus that cannot cause a disease, but helps a person to develop antibodies against …
FDA supports new medication for therapy of adults with chronic kidney infection Kumar Jeetendra | May 1, 2021 Today, the U.S. Food and Drug Administration accepted Farxiga (dapagliflozin) oral tablets to decrease the risk of kidney function decline, kidney failure, cardiovascular death and hospitalization for heart failure in adults with chronic kidney disease who are at risk of disease progression. Chronic kidney disease occurs when the kidneys are damaged and can’t filter blood …
Cipla enters into a licensing agreement with MSD to expand access to investigational oral therapeutic drug for COVID-19 treatment Kumar Jeetendra | April 28, 2021 Mumbai, India; April 28, 2021: Cipla Limited (BSE: 500087; NSE: CIPLA EQ; and hereafter referred to as “Cipla”) today announced that it has signed a non-exclusive licensing agreement with MSD a tradename of Merck & Co., Inc. Kenilworth, NJ., USA for the manufacturing and distribution of Molnupiravir, the investigational oral antiviral drug currently being studied …
Caplin Point Laboratories arm gets USFDA gesture for Neostigmine Methylsulfate Injection Kumar Jeetendra | April 22, 2021 New Delhi: Caplin Point Laboratories on Thursday said its subsidiary has received approval from the US health regulator for Neostigmine Methylsulfate Injection. Neostigmine Methylsulfate Injection is a cholinesterase inhibitor and is indicated for the reversal of the effects of non-depolariSing neuromuscular blocking agents (NMBAs) after surgery. “Caplin Steriles Ltd (Caplin) has been granted final approval …
Johnson and Johnson says in talks with Indian government for preliminary of single-portion vaccine Kumar Jeetendra | April 9, 2021 Johnson & Johnson is in talks with India’s government to start a clinical trial of its single-dose COVID-19 vaccine in the country, the company said on Friday. The U.S. drugs and health care giant’s vaccine is currently approved for use in the USA, the European Union and other countries including Thailand and South Africa. The …
